Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, February 06, 2018
AmerisourceBergen reported that in its fiscal year 2018 first quarter ended December 31, 2017, revenue increased 6.0 percent to $40.5 billion.
read more
Wednesday, October 02, 2019
AmerisourceBergen has been selected by Karyopharm Therapeutics to support XPOVIO™ (selinexor).
read more
Wednesday, November 22, 2017
AmerisourceBergen and H. D. Smith today announced that the companies have signed a definitive agreement under which AmerisourceBergen will purchase H. D. Smith for $815 million in cash.
read more
Tuesday, October 06, 2015
AmerisourceBergen has signed a definitive agreement to purchase PharMEDium Healthcare Holdings, Inc., the privately held leading national provider of outsourced compounded sterile prepa.rations (CSPs) to acute care hospitals in the United States, ...
read more
AmerisourceBergen has announced plans to build three new distribution centers in Olive Branch, MS; Shakopee, MN; and Newburgh, NY.
read more
Wednesday, September 04, 2019
AmEx has announces a voluntary recall of all Lots of Bevacizumab 1.25mg/0.05mL 31G Injectable and all Lots of Bevacizumab 2.5mg/0.1ml Normject TB Injectable.
read more
Wednesday, January 15, 2020
Amgen announced collaborations with diagnostic companies Guardant Health and QIAGEN to develop blood- and tissue-based companion diagnostics for investigational cancer treatment AMG 510.
read more
Amgen announced the groundbreaking of its new next-generation biomanufacturing plant that will be constructed at its West Greenwich, R.I. campus.
read more
Wednesday, August 23, 2017
GNS Healthcare has raised an additional $6 million in equity from Amgen Ventures with participation from existing investor Alexandria Real Estate Equities.
read more
Wednesday, August 19, 2015
Amgen will pay $71 million to settle an investigation into illegal marketing of its drugs Aranesp and Enbrel, ending an investigation by 48 states and Washington DC.
read more
On 22 May 2019 Amgen announced a recommended public cash offer to the shareholders of Nuevolution to tender all their shares in Nuevolution to Amgen for SEK 32.50 per share in cash.
read more
Monday, December 16, 2019
Amgen announced the signing of a lease with BioMed Realty for a 240,000-square-foot LEED candidate facility in the Gateway of Pacific campus development in South San Francisco.
read more
Thursday, September 17, 2015
Amgen and Dezima Pharma B.V. have entered into a definitive acquisition agreement under which Amgen will acquire Dezima, a privately-held, Netherlands-based biotechnology company focused on developing innovative treatments for dyslipidemia.
read more
Thursday, August 29, 2013
Amgen and Onyx Pharmaceuticals, Inc. today announced that their Boards of Directors have unanimously approved a transaction under which Amgen will acquire all of the outstanding shares of Onyx for $125 per share in cash. The purchase price is $10.4 ...
read more
Amgen has announced plans to build a new state-of-the-art next-generation biomanufacturing plant at its campus in West Greenwich, R.I.
read more